The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of the Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 18 in the nation by U.S. News & World Report® for 2023-24.
The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of the Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 18 in the nation by U.S. News & World Report® for 2023-24.
